No one has been a bigger champion for patients in the fight to lower Rx drug prices than Sen Amy Klobuchar. We are so lucky to have her as a leader on our side. Great interview here. keyc.com/2024/04/11/spe…

Gunnar Esiason Glenn Youngkin Good man *for the pharmaceutical industry. That veto harms patients and ultimately degrades equitable access to lifesaving drugs.

The teach-in is happening now. It is truly unconscionable that with margins like this, Vertex Pharmaceuticals will let kids die rather than lower its price. It's hard to fathom how the officials of this company sleep at night.

FACTS VS. PHARMA FEARMONGERING:
Contrary to VC and drug company propaganda, this is not an industry shrinking away from early stage investment in innovation & new drug development as a result of the IRA. statnews.com/2024/04/09/bio…

What a shame. @governorva Glenn Youngkin sides w/the drug companies to block a prescription drug affordability board to lower prices for the people of his state. 13newsnow.com/article/news/g…

It's an outrage.
This CEO-an MD no less-is getting a 30% increase in pay to more than $20 million by charging predatory prices for a drug built on NIH funded research. She's willing to let kids die in some cases rather than lower prices. fiercepharma.com/pharma/vertex-…

P4AD patient advocate Kris Garcia feels empowered by sharing his experiences with high drug prices because he knows he's helping create change. Have you or a loved one been prescribed a medication you struggled to afford? Share your story: secure.everyaction.com/SvIaRhn3VEmVAk…

We've made historic progress in lowering drug prices thru the Inflation Reduction Act. But there is more to do. These two rivals want to take the lead in next steps, and we are pushing as hard as we can in the same direction. cnn.com/2024/04/03/pol…

One of the most thoughtful, balanced think tanks in the country led by Republican Avik Roy Roy shows why drug industry claims that high prices drive innovation don't hold water. I don't agree w/every point, but it's a must read.
washingtonpost.com/opinions/2024/…

80% of Americans support the new law directing Medicare to negotiate lower Rx prices. Drug companies are fighting in the courts to overturn the will of the people. They've filed 9 lawsuits. Join US to stand against this industry that puts its profits before the needs of people.

David Mitchell The Medicare program has been a godsend to me. I have Type1 Diabetes. The $35 insulin really helps this senior’s budget.

When elected officials stand up for patients to lower the prices of Rx drugs, our patient advocates are proud to stand with them. @KrisFGarcia did wonderful job telling his story today at the White House. Thank you, Kris!

Offer.
Counteroffer.
Back and forth.
Our govt is negotiating with drug companies on our behalf for a better deal--not 'price setting' as pharma and its allies in Congress keep saying. reuters.com/business/healt…

.AbbVie is boasting that it is making the 'big bets' on R&D & new drugs. Companies don't make big bets if they feel the outlook for making money is poor. So the IRA clearly isn't a barrier to investment and new drug development.
endpts.com/abbvie-commits…

56% of Medicare enrollees w/Part D coverage are women. And they are going to see real savings from the IRA. In 2025, the oop cap & other provisions are projected to save women in Medicare an average of 28% in oop costs--about $128 on average. managedhealthcareexecutive.com/view/the-ira-s…

Women on Medicare, a group disproportionally affected by high health care costs, will see savings on their prescriptions thanks to the Inflation Reduction Act. P4AD joined HHS.gov and allies to learn how Medicare negotiation helps women across the US save on the drugs they need.

Drug companies game our patent system to extend monopolies, raise prices and keep them high. Sham patents are one way they do it. Bipartisan legislation in Congress seeks to stop many drug company patent abuses. patientspushforcompetition.org

Net prices of Rx drugs fall due to competition we've fought for, but that was too long delayed. List price increases slowing because of inflation caps in IRA. Out-of-pocket limits phasing in saving patients $$.
We are making progress but much more to do. statnews.com/pharmalot/2024…

It's unfortunate that Republicans in Congress are advocating higher drug prices by repealing Medicare's power to negotiate lower prices. Sadly, they rely on outdated & misleading data prepared by Tomas Philipson who works for the drug companies. rollingstone.com/politics/polit…

More evidence of continued interest and investment in small molecule drugs. Pharma fearmongering vs. facts.
endpts.com/boundless-star…